KORU Medical Systems (KRMD) Form 3 KORU Medical Systems / Christopher Pazdan ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Pazdan Christopher

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NJ 07430

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/18/2024

3. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,085	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	(1)	09/15/2031	Common Stock	200,000	3.11	D
Option to Purchase Common Stock	(2)	03/15/2034	Common Stock	20,000	2.2	D
Performance Share Units	(3)	(3)	Common Stock	54,496	(3)	D

Explanation of Responses:

1. Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 09/15/2021 date of the grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.

2. Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 03/15/2024 date of the grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.

3. Granted on 04/24/24. Vesting is dependent upon the achievement by KORU Medical Systems, Inc. of certain performance criteria. Thue number of performance share units scheduled to vest on December 31, 2024 will vary between 0% and 150% of the number reported, depending on whether and the extent to which the performance criteria are met. Performance share units are paid out in shares of KORU Medical Systems, Inc.'s common stock on a one-for-one basis.

Remarks:

Power of Attorney filed herewith as Exhibit 24.

	/s/ Thomas Adams Attorney-In-Fact	07/31/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.